Skip to main content
Livermore
Livermore
ZHEN

Geode Capital Management, LLC

SEC CIK
0001214717
Latest filing
Aug 12, 2026

CBIO holding history

Crescent Biopharma, Inc. in every 13F filed by Geode Capital Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CBIO overviewAll 13F holders of CBIOFull Q2 2026 holdings

Shares (Q2 2026)
384,576
Value
$6.92M
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of CBIO by Geode Capital Management, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026384,576$6.92M<0.1%+280,355+269.0%AddedHolders
Q1 2026104,221$1.92M<0.1%+13,142+14.4%AddedHolders
Q4 202591,079$1.08M<0.1%+21,945+31.7%AddedHolders
Q3 202569,134$822.0K<0.1%+69,134NewHolders
Q2 20250$00.0%−571,726−100.0%Sold outHolders
Q1 2025571,726$120.1K<0.1%+50,503+9.7%AddedHolders
Q4 2024521,223$129.8K<0.1%00.0%UnchangedHolders
Q3 2024521,223$88.1K<0.1%+33,981+7.0%AddedHolders
Q2 2024487,242$137.2K<0.1%−17,905−3.5%ReducedHolders
Q1 2024505,147$1.52M<0.1%+26,264+5.5%AddedHolders
Q4 2023478,883$1.13M<0.1%+19,038+4.1%AddedHolders
Q3 2023459,845$690.0K<0.1%−16,395−3.4%ReducedHolders
Q2 2023476,240$828.7K<0.1%+70,905+17.5%AddedHolders
Q1 2023405,335$510.7K<0.1%00.0%UnchangedHolders
Q4 2022405,335$1.23M<0.1%+46,940+13.1%AddedHolders
Q3 2022358,395$197.0K<0.1%00.0%UnchangedHolders
Q2 2022358,395$214.0K<0.1%−5,042−1.4%ReducedHolders
Q1 2022363,437$414.0K<0.1%−1,669−0.5%ReducedHolders
Q4 2021365,106$525.0K<0.1%−1,195−0.3%ReducedHolders
Q3 2021366,301$802.0K<0.1%+13,561+3.8%AddedHolders
Q2 2021352,740$818.0K<0.1%−367,439−51.0%ReducedHolders
Q1 2021720,179$2.17M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.